Cargando…
Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719089/ https://www.ncbi.nlm.nih.gov/pubmed/34587718 http://dx.doi.org/10.3324/haematol.2021.278655 |
| _version_ | 1784624865499676672 |
|---|---|
| author | Kalff, Anna Khong, Tiffany Ramachandran, Malarmathy Ho, P Joy Mollee, Peter D’Rozario, James Taylor, Kerry Estell, Jane Norton, Sam Kemp, Roslyn Mitchell, Andrew J. Reynolds, John Kennedy, Nola Quach, Hang Spencer, Andrew |
| author_facet | Kalff, Anna Khong, Tiffany Ramachandran, Malarmathy Ho, P Joy Mollee, Peter D’Rozario, James Taylor, Kerry Estell, Jane Norton, Sam Kemp, Roslyn Mitchell, Andrew J. Reynolds, John Kennedy, Nola Quach, Hang Spencer, Andrew |
| author_sort | Kalff, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8719089 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87190892022-01-14 Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) Kalff, Anna Khong, Tiffany Ramachandran, Malarmathy Ho, P Joy Mollee, Peter D’Rozario, James Taylor, Kerry Estell, Jane Norton, Sam Kemp, Roslyn Mitchell, Andrew J. Reynolds, John Kennedy, Nola Quach, Hang Spencer, Andrew Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-09-30 /pmc/articles/PMC8719089/ /pubmed/34587718 http://dx.doi.org/10.3324/haematol.2021.278655 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Kalff, Anna Khong, Tiffany Ramachandran, Malarmathy Ho, P Joy Mollee, Peter D’Rozario, James Taylor, Kerry Estell, Jane Norton, Sam Kemp, Roslyn Mitchell, Andrew J. Reynolds, John Kennedy, Nola Quach, Hang Spencer, Andrew Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) |
| title | Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) |
| title_full | Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) |
| title_fullStr | Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) |
| title_full_unstemmed | Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) |
| title_short | Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) |
| title_sort | planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (allg mm14) |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719089/ https://www.ncbi.nlm.nih.gov/pubmed/34587718 http://dx.doi.org/10.3324/haematol.2021.278655 |
| work_keys_str_mv | AT kalffanna plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT khongtiffany plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT ramachandranmalarmathy plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT hopjoy plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT molleepeter plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT drozariojames plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT taylorkerry plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT estelljane plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT nortonsam plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT kemproslyn plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT mitchellandrewj plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT reynoldsjohn plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT kennedynola plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT quachhang plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 AT spencerandrew plannedwithdrawalofdexamethasoneafterpomalidomidelowdosedexamethasoneinductionforlenalidomiderefractorymultiplemyelomaallgmm14 |